Sarcoma response to targeted therapy dynamically polarizes tumor-associated macrophages

OncoImmunology

Volumn 3, Issue 4, 2014, Pages

  Cavnar, Michael J ^a   DeMatteo, Ronald P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

C EBP ; CSF1R; Gastrointestinal stromal tumor; Macrophage; Tumor associated macrophage

Indexed keywords

B7 ANTIGEN; CD16 ANTIGEN; CD32 ANTIGEN; CD45 ANTIGEN; CD64 ANTIGEN; CD86 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMATINIB; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STEM CELL FACTOR RECEPTOR;

ANTIGEN PRESENTATION; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL INTERACTION; CELL POLARITY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG RESPONSE; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; LYMPHOCYTE PROLIFERATION; MACROPHAGE FUNCTION; NONHUMAN; NOTE; ONCOGENE C KIT; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR PROMOTION; UPREGULATION;

EID: 84902595569     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.28463     Document Type: Note

References (6)

1. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11:889-96; PMID:20856220 http://dx.doi.org/10.1038/ni.1937
2. Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med 2011; 9:216; PMID:22176642; http://dx.doi. org/10.1186/1479-5876-9-216
3. Cavnar MJ, Zeng S, Kim TS, Sorenson EC, Ocuin LM, Balachandran VP, Seifert AM, Greer JB, Popow R, Crawley MH, et al. KIT oncogene inhibition drives intratumoral macrophage M2 polarization. J Exp Med 2013; 210:2873-86; PMID:24323358 http://dx.doi.org/10.1084/jem.20130875
4. Joensuu H, DeMatteo RP. The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy. Annu Rev Med 2012; 63:247-58; PMID:22017446 http:// dx.doi.org/10.1146/annurev-med-043010-091813
5. Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, et al. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res 2005; 11:4182-90; PMID:15930355 http://dx.doi. org/10.1158/1078-0432.CCR-04-2245
6. Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG, Rosenthal N, Nerlov C. A CREB-C/ EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci U S A 2009; 106:17475-80; PMID:19805133 http://dx.doi.org/10.1073/ pnas.0908641106